Peptide-based agents for cancer treatment: Current applications and future directions
Peptide-based strategies have received an enormous amount of attention because of their
specificity and applicability. Their specificity and tumor-targeting ability are applied to …
specificity and applicability. Their specificity and tumor-targeting ability are applied to …
Targeting transcription factors ATF5, CEBPB and CEBPD with cell-penetrating peptides to treat brain and other cancers
LA Greene, Q Zhou, MD Siegelin, JM Angelastro - Cells, 2023 - mdpi.com
Developing novel therapeutics often follows three steps: target identification, design of
strategies to suppress target activity and drug development to implement the strategies. In …
strategies to suppress target activity and drug development to implement the strategies. In …
Effect of the Lipid Landscape on the Efficacy of Cell-Penetrating Peptides
Every cell biological textbook teaches us that the main role of the plasma membrane is to
separate cells from their neighborhood to allow for a controlled composition of the …
separate cells from their neighborhood to allow for a controlled composition of the …
A straightforward method for the development of positively charged gold nanoparticle-based vectors for effective siRNA delivery
TN Elizarova, ML Antopolsky, DO Novichikhin… - Molecules, 2023 - mdpi.com
The therapeutic potential of short interfering RNA (siRNA) to treat many diseases that are
incurable with traditional preparations is limited by the extensive metabolism of serum …
incurable with traditional preparations is limited by the extensive metabolism of serum …
Cell Penetrating Peptides: Classification, Mechanisms, Methods of Study, and Applications
A Gori, G Lodigiani, SG Colombarolli… - …, 2023 - Wiley Online Library
Cell‐penetrating peptides (CPPs) encompass a class of peptides that possess the
remarkable ability to cross cell membranes and deliver various types of cargoes, including …
remarkable ability to cross cell membranes and deliver various types of cargoes, including …
Prediction of drug synergism between peptides and antineoplastic drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin using in silico approaches
N Vale, M Pereira, J Santos, C Moura… - International Journal of …, 2022 - mdpi.com
Chemotherapy is the main treatment for most early-stage cancers; nevertheless, its efficacy
is usually limited by drug resistance, toxicity, and tumor heterogeneity. Cell-penetrating …
is usually limited by drug resistance, toxicity, and tumor heterogeneity. Cell-penetrating …
Cell penetrating peptides: Highlighting points in cancer therapy
AM Asrorov, H Wang, M Zhang, Y Wang… - Drug Development …, 2023 - Wiley Online Library
Abstract Cell‐penetrating peptides (CPPs), first identified in HIV a few decades ago,
deserved great attention in the last two decades; especially to support the penetration of …
deserved great attention in the last two decades; especially to support the penetration of …
[HTML][HTML] Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90/Cdc37 interaction for treating hepatocellular …
S Sukumaran, M Tan, SF Ben-Uliel, H Zhang… - Computational and …, 2023 - Elsevier
Abstract Heat shock protein 90 (Hsp90) and cell division cycle 37 (Cdc37) work together as
a molecular chaperone complex to regulate the activity of a multitude of client protein …
a molecular chaperone complex to regulate the activity of a multitude of client protein …
Cell Penetrability of a γ-Crystallin Peptide Fragment from the Discarded Cataractous Eye Emulsion
The efficiency of the intracellular transport of medication and target specificity is frequently
hampered by biological obstacles. The potential for therapeutic use of peptide fragments …
hampered by biological obstacles. The potential for therapeutic use of peptide fragments …
A Nucleus-Targeting WT1 Antagonistic Peptide Encapsulated in Polymeric Nanomicelles Combats Refractory Chronic Myeloid Leukemia
M Chen, X Fang, R Du, J Meng, J Liu, M Liu, Y Yang… - Pharmaceutics, 2023 - mdpi.com
Chronic myeloid leukemia (CML) is recognized as a classic clonal myeloproliferative
disorder. Given the limited treatment options for CML patients in the accelerated phase (AP) …
disorder. Given the limited treatment options for CML patients in the accelerated phase (AP) …